576 related articles for article (PubMed ID: 19034029)
1. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
[TBL] [Abstract][Full Text] [Related]
2. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
[TBL] [Abstract][Full Text] [Related]
3. Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status.
Vaillant F; Dehina L; Dizerens N; Bui-Xuan B; Tabib A; Lauzier B; Chevalier P; Descotes J; Timour Q
Resuscitation; 2013 Mar; 84(3):384-90. PubMed ID: 22940600
[TBL] [Abstract][Full Text] [Related]
4. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
[TBL] [Abstract][Full Text] [Related]
5. Effects of transient myocardial ischemia on the ventricular defibrillation threshold.
Anastasiou-Nana MI; Tsagalou EP; Charitos C; Siafakas KX; Drakos S; Terrovitis JV; Ntalianis A; Doufas A; Mavrikakis J; Nanas JN
Pacing Clin Electrophysiol; 2005 Feb; 28(2):97-101. PubMed ID: 15679638
[TBL] [Abstract][Full Text] [Related]
6. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
7. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
[TBL] [Abstract][Full Text] [Related]
8. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of ventricular fibrillation dominant frequency during global ischemia in isolated rabbit hearts.
Caldwell J; Burton FL; Smith GL; Cobbe SM
J Cardiovasc Electrophysiol; 2007 Aug; 18(8):854-61. PubMed ID: 17553077
[TBL] [Abstract][Full Text] [Related]
10. Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.
Monnet X; Ghaleh B; Colin P; de Curzon OP; Giudicelli JF; Berdeaux A
J Pharmacol Exp Ther; 2001 Dec; 299(3):1133-9. PubMed ID: 11714904
[TBL] [Abstract][Full Text] [Related]
11. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
[TBL] [Abstract][Full Text] [Related]
12. Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
Monnet X; Colin P; Ghaleh B; Hittinger L; Giudicelli JF; Berdeaux A
Eur Heart J; 2004 Apr; 25(7):579-86. PubMed ID: 15120055
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological, haemodynamic, and mitochondrial alterations induced by levobupivacaine during myocardial ischemia in a pig model: protection by lipid emulsions?
Mamou Z; Descotes J; Chevalier P; Bui-Xuan B; Romestaing C; Timour Q
Fundam Clin Pharmacol; 2015 Oct; 29(5):439-49. PubMed ID: 26118736
[TBL] [Abstract][Full Text] [Related]
14. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
Timour Q; Aupetit JF; Freysz M; Frassati D; Faucon G
Can J Physiol Pharmacol; 1996 Dec; 74(12):1308-14. PubMed ID: 9047040
[TBL] [Abstract][Full Text] [Related]
15. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
16. Effects of ganglionated plexi ablation on ventricular electrophysiological properties in normal hearts and after acute myocardial ischemia.
He B; Lu Z; He W; Wu L; Cui B; Hu X; Yu L; Huang C; Jiang H
Int J Cardiol; 2013 Sep; 168(1):86-93. PubMed ID: 23041007
[TBL] [Abstract][Full Text] [Related]
17. Changes of endothelin-1 and big endothelin-1 levels and action potential duration during myocardial ischemia-reperfusion in dogs with and without ventricular fibrillation.
Vágó H; Soós P; Zima E; Gellér L; Keltai K; Róka A; Kékesi V; Juhász-Nagy A; Merkely B
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S376-9. PubMed ID: 15838324
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic impact of the left ventricular pacing site during graded ischaemia in an open-chest pig model.
Bordachar P; Labrousse L; Thambo JB; Reant P; Lafitte S; O'Neill MD; Jais P; Haissaguerre M; Clementy J; Dos Santos P
Europace; 2008 Feb; 10(2):242-8. PubMed ID: 18256130
[TBL] [Abstract][Full Text] [Related]
19. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
Linz D; Wirth K; Ukena C; Mahfoud F; Pöss J; Linz B; Böhm M; Neuberger HR
Heart Rhythm; 2013 Oct; 10(10):1525-30. PubMed ID: 23851058
[TBL] [Abstract][Full Text] [Related]
20. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
